These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 12063370

  • 1. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.
    N Engl J Med; 2002 Jun 13; 346(24):1863-70. PubMed ID: 12063370
    [Abstract] [Full Text] [Related]

  • 2. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
    Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ.
    J Infect Dis; 2006 May 01; 193(9):1195-201. PubMed ID: 16586354
    [Abstract] [Full Text] [Related]

  • 3. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG, Pediatric Spectrum of HIV Disease Consortium.
    Pediatrics; 2007 Apr 01; 119(4):e900-6. PubMed ID: 17353299
    [Abstract] [Full Text] [Related]

  • 4. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
    Szyld EG, Warley EM, Freimanis L, Gonin R, Cahn PE, Calvet GA, Duarte G, Melo VH, Read JS, NISDI Perinatal Study Group.
    AIDS; 2006 Nov 28; 20(18):2345-53. PubMed ID: 17117021
    [Abstract] [Full Text] [Related]

  • 5. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
    Martí C, Peña JM, Bates I, Madero R, de José I, Pallardo LF, Arribas JR, Gonzalez-Garcia J, Gonzalez A, Vazquez JJ.
    Acta Obstet Gynecol Scand; 2007 Nov 28; 86(4):409-15. PubMed ID: 17486461
    [Abstract] [Full Text] [Related]

  • 6. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 7. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
    Kourtis AP, Schmid CH, Jamieson DJ, Lau J.
    AIDS; 2007 Mar 12; 21(5):607-15. PubMed ID: 17314523
    [Abstract] [Full Text] [Related]

  • 8. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J, Warszawski J, Tubiana R, Dollfus C, Faye A, Rouzioux C, Teglas JP, Ekoukou D, Blanche S, Mandelbrot L.
    Clin Infect Dis; 2012 May 12; 54(9):1348-60. PubMed ID: 22460969
    [Abstract] [Full Text] [Related]

  • 9. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
    Grosch-Woerner I, Puch K, Maier RF, Niehues T, Notheis G, Patel D, Casteleyn S, Feiterna-Sperling C, Groeger S, Zaknun D, Multicenter Interdisciplinary Study Group Germany/Austria.
    HIV Med; 2008 Jan 12; 9(1):6-13. PubMed ID: 18199167
    [Abstract] [Full Text] [Related]

  • 10. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL.
    N Engl J Med; 1994 Nov 03; 331(18):1173-80. PubMed ID: 7935654
    [Abstract] [Full Text] [Related]

  • 11. Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy.
    Livingston EG, Cohn SE, Yang Y, Watts HD, Bardeguez AD, Jones TB, Smith LM, Umbleja T, McComsey GA.
    Obstet Gynecol; 2007 Aug 03; 110(2 Pt 1):391-7. PubMed ID: 17666616
    [Abstract] [Full Text] [Related]

  • 12. Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy.
    Melvin AJ, Kang M, Hitti J, Livingston E, Cohn SE, Stocker V, Ross AC, Watts H, McComsey GA.
    Antivir Ther; 2008 Aug 03; 13(3):349-55. PubMed ID: 18572747
    [Abstract] [Full Text] [Related]

  • 13. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
    Joseph O, Biodun O, Michael E.
    J Coll Physicians Surg Pak; 2011 Jun 03; 21(6):356-9. PubMed ID: 21711992
    [Abstract] [Full Text] [Related]

  • 14. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
    Haeri S, Shauer M, Dale M, Leslie J, Baker AM, Saddlemire S, Boggess K.
    Am J Obstet Gynecol; 2009 Sep 03; 201(3):315.e1-5. PubMed ID: 19733286
    [Abstract] [Full Text] [Related]

  • 15. Lack of effect on prematurity, birth weight, and infant growth from exposure to protease inhibitors in utero and after birth.
    Carceller A, Ferreira E, Alloul S, Lapointe N.
    Pharmacotherapy; 2009 Nov 03; 29(11):1289-96. PubMed ID: 19857146
    [Abstract] [Full Text] [Related]

  • 16. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.
    Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR, Song LY, Dankner WM, Oleske JM, Pediatric AIDS Clinical Trials Group Protocol 219 Team.
    N Engl J Med; 2001 Nov 22; 345(21):1522-8. PubMed ID: 11794218
    [Abstract] [Full Text] [Related]

  • 17. Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth.
    Surkan PJ, Stephansson O, Dickman PW, Cnattingius S.
    N Engl J Med; 2004 Feb 19; 350(8):777-85. PubMed ID: 14973215
    [Abstract] [Full Text] [Related]

  • 18. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
    Azria E, Moutafoff C, Schmitz T, Le Meaux JP, Krivine A, Pannier E, Firtion G, Compagnucci A, Finkielsztejn L, Taulera O, Tsatsaris V, Cabrol D, Launay O.
    Antivir Ther; 2009 Feb 19; 14(3):423-32. PubMed ID: 19474476
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, Whitehouse J, Moye J, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.
    N Engl J Med; 1999 Aug 05; 341(6):385-93. PubMed ID: 10432323
    [Abstract] [Full Text] [Related]

  • 20. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK, NISDI Perinatal Study Group.
    Obstet Gynecol; 2007 Jun 05; 109(6):1358-67. PubMed ID: 17540808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.